ELRIG’s Post

ELRIG has announced the keynote speakers for #Research & #Innovation 2025 taking place at the 📍Royal Society of Medicine, 1 Wimpole Street from 📅10–11 March. Dr Jue Wang , Research Scientist and Co-lead of the Protein Design Team at Google DeepMind, and Dr Robert Grundy MBE, CEO of Intelligent OMICS Ltd, will lead this year’s event focussed on '#bigmolecules to #bigdata …thinking BIG to drive innovative research’. #ELRIGRI2025 will cover: 💡Big technology for big molecules — focussed on new and innovative technologies that are used for drug discovery and development of biotherapeutic drugs 💡Big molecules for big problems — exploring the innovative potential of large molecules in treating diseases and the hurdles in their development 💡Big data for big insights: transforming research — which will examine how big data and AI are advancing our ability to target complex diseases Read the press release 🗞 https://lnkd.in/ezAJzGv5 Registration is free 👉 https://lnkd.in/eKwMJNM3 Sarah Brockbank Roger Clark #RI2025 #researchandinnovation #drugdiscovery #lifesciences #pharma #biotechnology #emergingtechnologies #networking #innovation #messengersinscience

Want to learn how to accelerate early-stage discoveries and efficiently identify key disease markers for drug discovery? Then join our webinar on Tuesday, 16 July 2024, at 5 pm CEST / 11 am EDT! Integrating multiple biological data types, also known as Multiomics, is an innovative approach for early-phase discoveries. By contextualizing this data, scientists gain a holistic view of biological processes and their relationships and patterns that are otherwise overlooked. Knowledge graphs provide a robust framework for such comprehensive analyses and accelerate the discovery of new therapies while reducing time and costs. At knowing01, we have developed an easy-to-use software that decodes the complex interplay of Multiomics data to identify therapeutically relevant disease markers. Sounds interesting? Then join our webinar: When? Tuesday, 16 July 2024, at 5pm CEST / 11am EDT Duration? 15 minutes Where? Online Dr. Nikola Müller, CEO & Founder of knowing01, and Karolina Worf, Online Content Manager at knowing01, will talk about "Contextualize Multiomics data with knowledge graphs for early-phase discoveries". More information and registration: https://lnkd.in/dpGvCU6r #WomenInIT #Webinar #Research #Omics #Multiomics #KnowledgeGraphs #knowing01 #Innovation #FemaleLeaders #DrugDiscovery #DataScience #DataIntegration #DataAnalysis #Biotechnology

Register now for our webinar on Tuesday, 16 July 2024, at 5pm CEST / 11am EDT to learn more about how to contextualize Multiomics data to accelerate early-phase discoveries in drug development. The integration of multiple biological data types, also known as Multiomics, is an innovative approach to early-phase discoveries. By contextualizing this data, scientists gain a holistic view of biological processes and their relationships that are otherwise overlooked. Knowledge graphs provide a robust framework for such comprehensive analysis while reducing time and cost. At knowing01, we have developed an easy-to-use software that decodes the complex interplay of Multiomics data to identify therapeutically relevant disease markers. Want to learn more? Join our webinar: When? Tuesday, 16 July 2024, at 5pm CEST / 11am EDT Duration? 15 minutes Where? Online Dr. Nikola Müller, CEO & Founder of knowing01, and Karolina Worf, Online Content Manager at knowing01, will talk about "Contextualize Multiomics data with knowledge graphs for early-phase discoveries". More information and registration: https://lnkd.in/dpGvCU6r #WomenInIT #Webinar #Research #Omics #Multiomics #KnowledgeGraphs #knowing01 #Innovation #FemaleLeaders #DrugDiscovery #DataScience #DataIntegration #DataAnalysis #Biotechnology

🌟 Phenotypic drug discovery has delivered transformative therapies—but are we at the start of a new wave or nearing the end of an era? Will emerging tools like AI and advanced imaging, coupled with market shifts like increased open innovation, elevate phenotypic drug discovery to new heights? Or will the high costs of automation limit new players, and cellular models fall short in clinical translation? Share your perspective in an anonymous 3-minute survey on the future of phenotypic drug discovery 🔗 https://lnkd.in/es2Snj7P Results will be unveiled during the Future of Phenotypic Drug Discovery panel at #SLAS2025 in San Diego—and shared with the broader community afterward on LinkedIn. If you're attending SLAS2025 in San Diego, I'll be chairing a panel the morning of January 28th that brings together leaders in Phenotypic Drug Discovery, to discuss where the field is headed. Comment below to learn more or you'd like to meet up at SLAS! #DrugDiscovery #PhenotypicScreening #InnovationInScience #AIInBiotech #SLAS2025 #LifeSciences

Collaboration and advanced technology are transforming the landscape of medical research and drug development. Maksymilian Karczewski, Ph.D. discusses the inspiration and vision behind the founding of Allchemy, a trailblazer in AI-driven drug discovery, highlighting the strategic partnership with SciY 👇 #Allchemy #SciY

Collaboration and advanced technology are transforming the landscape of medical research and drug development. Maksymilian Karczewski, Ph.D. discusses the inspiration and vision behind the founding of Allchemy, a trailblazer in AI-driven drug discovery, highlighting the strategic partnership with SciY 👇 #Allchemy #SciY

Collaboration and advanced technology are transforming the landscape of medical research and drug development. Maksymilian Karczewski, Ph.D. discusses the inspiration and vision behind the founding of Allchemy, a trailblazer in AI-driven drug discovery, highlighting the strategic partnership with SciY 👇 #Allchemy #SciY

The Role of Genomics in Modern Healthcare Genomics is at the forefront of a new era in healthcare, where personalized medicine is becoming the norm. By understanding the genetic makeup of individuals, we can develop more targeted and effective treatments for a variety of diseases. At Genomac Holdings, we're leveraging the power of genomics to drive innovation in healthcare, from research to real-world applications. Our work is not just about advancing science; it's about making a tangible difference in people's lives. As we continue to explore the potential of genomics, we're excited to share our findings and collaborate with global stakeholders to push the boundaries of what's possible in healthcare. #Genomics #HealthcareInnovation #PersonalizedMedicine #Biotech #Innovation

We've made some really cool advances in spectral unmixing for flow cytometry, solving many of the problems plaguing high dimensional spectral technology. The result is: better signal to noise, consistent background across markers, and low spreading error. This means Ozette's customers are measuring real biology and not technical assay artefacts. Come talk to us about it at ASH, and find out how we can help you.

New alternative methods (NAMs) are gaining momentum as researchers seek ways to reduce the need for research models, but are they viable solutions to advance drug discovery and development? Find out from our expert in our latest edition of Sounds of Science. Listen and subscribe: https://okt.to/XVtZCE